PICK1 and nasopharyngeal carcinoma: Next, we examined the expression of β-catenin in NPC cells treated with MG132, an 26 S protostome inhibitor, and observed that MG132 reversed the downregulation of β-catenin protein induced by PICK1 (Fig. 8E).